|
Volumn 10, Issue 4, 2006, Pages
|
Measuring the anticoagulant effect of low molecular weight heparins in the critically ill
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD CLOTTING FACTOR 10A INHIBITOR;
DALTEPARIN;
HEPARIN;
INOTROPIC AGENT;
LOW MOLECULAR WEIGHT HEPARIN;
ANTICOAGULANT AGENT;
ANTICOAGULATION;
AREA UNDER THE CURVE;
ARTIFICIAL VENTILATION;
CRITICAL ILLNESS;
CRITICALLY ILL PATIENT;
DEEP VEIN THROMBOSIS;
DISEASE PREDISPOSITION;
DRUG ABSORPTION;
DRUG ANTAGONISM;
DRUG BLOOD LEVEL;
DRUG TREATMENT FAILURE;
HIGH RISK PATIENT;
HOSPITALIZATION;
HUMAN;
INTENSIVE CARE;
LENGTH OF STAY;
LUNG EMBOLISM;
MORTALITY;
NOTE;
PRIORITY JOURNAL;
SKIN EDEMA;
THROMBOEMBOLISM;
THROMBOSIS PREVENTION;
INTRADERMAL DRUG ADMINISTRATION;
VENOUS THROMBOSIS;
ADMINISTRATION, CUTANEOUS;
ANTICOAGULANTS;
CRITICAL ILLNESS;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HUMANS;
VENOUS THROMBOSIS;
|
EID: 34447625380
PISSN: 13648535
EISSN: 1466609X
Source Type: Journal
DOI: 10.1186/cc4978 Document Type: Note |
Times cited : (4)
|
References (4)
|